【产品概况】
产品名称:Human VEGFR2 / KDR / CD309 Antibody (AT001, Research Use)
产品编号:NBR-0938
针对靶点:VEGFR2 / KDR / CD309
抗体药商品名:AT001
抗体药描述:AT-001 is an investigational, novel Aldose Reductase Inhibitor (ARI) being developed as an oral therapy for the treatment of Diabetic Cardiomyopathy (DbCM). AT-001 is currently being studied in a Phase 3 registrational study in DbCM.
【产品参数】
产品外观:Transparent Liquid
分子量:~150kDa
CAS:N/A
溶解度:Water; PBS, TBS Buffer等
表达系统:CHO Expressed
抗体亚型:Ab. Isotype - IgG
【基因信息】
Gene Name: KDR
Synonyms: CD309; FLK1; VEGFR; VEGFR2
Target Description: Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFA, VEGFC and VEGFD. Plays an essential role in the regulation of angiogenesis, vascular development, vascular permeability, and embryonic hematopoiesis.
Ensembl: ENSG00000128052
Uniprot: P35968